These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35482831)

  • 41. Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension.
    Sharmin N; Nganwuchu CC; Nasim MT
    Trends Pharmacol Sci; 2021 Jul; 42(7):510-513. PubMed ID: 33966900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial cells in the pathogenesis of pulmonary arterial hypertension.
    Evans CE; Cober ND; Dai Z; Stewart DJ; Zhao YY
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33509961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
    Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY
    Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Pharmacological Targets for Pulmonary Arterial Hypertension.
    Klinger JR
    Compr Physiol; 2021 Sep; 11(4):2297-2349. PubMed ID: 34558669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling.
    Kurakula K; Hagdorn QAJ; van der Feen DE; Vonk Noordegraaf A; Ten Dijke P; de Boer RA; Bogaard HJ; Goumans MJ; Berger RMF
    Angiogenesis; 2022 Feb; 25(1):99-112. PubMed ID: 34379232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
    Morrell NW
    Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
    Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
    Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.
    Shintani M; Yagi H; Nakayama T; Saji T; Matsuoka R
    J Med Genet; 2009 May; 46(5):331-7. PubMed ID: 19211612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
    Eichstaedt CA; Saßmannshausen Z; Shaukat M; Cao D; Xanthouli P; Gall H; Sommer N; Ghofrani HA; Seyfarth HJ; Lerche M; Halank M; Kleymann J; Benjamin N; Harutyunova S; Egenlauf B; Milger K; Rosenkranz S; Ewert R; Klose H; Hoeper MM; Olsson KM; Lankeit M; Lange TJ; Hinderhofer K; Grünig E
    Respir Res; 2022 Mar; 23(1):74. PubMed ID: 35346192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
    Santos-Gomes J; Le Ribeuz H; Brás-Silva C; Antigny F; Adão R
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex and gender in pulmonary arterial hypertension.
    Cheron C; McBride SA; Antigny F; Girerd B; Chouchana M; Chaumais MC; Jaïs X; Bertoletti L; Sitbon O; Weatherald J; Humbert M; Montani D
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34750113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schistosomiasis Pulmonary Arterial Hypertension.
    Sibomana JP; Campeche A; Carvalho-Filho RJ; Correa RA; Duani H; Pacheco Guimaraes V; Hilton JF; Kassa B; Kumar R; Lee MH; Loureiro CMC; Mazimba S; Mickael C; Oliveira RKF; Ota-Arakaki JS; Rezende CF; Silva LCS; Sinkala E; Ahmed HY; Graham BB
    Front Immunol; 2020; 11():608883. PubMed ID: 33362796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension.
    Fazal S; Bisserier M; Hadri L
    Cells; 2021 Mar; 10(3):. PubMed ID: 33805595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.
    Gräf S; Haimel M; Bleda M; Hadinnapola C; Southgate L; Li W; Hodgson J; Liu B; Salmon RM; Southwood M; Machado RD; Martin JM; Treacy CM; Yates K; Daugherty LC; Shamardina O; Whitehorn D; Holden S; Aldred M; Bogaard HJ; Church C; Coghlan G; Condliffe R; Corris PA; Danesino C; Eyries M; Gall H; Ghio S; Ghofrani HA; Gibbs JSR; Girerd B; Houweling AC; Howard L; Humbert M; Kiely DG; Kovacs G; MacKenzie Ross RV; Moledina S; Montani D; Newnham M; Olschewski A; Olschewski H; Peacock AJ; Pepke-Zaba J; Prokopenko I; Rhodes CJ; Scelsi L; Seeger W; Soubrier F; Stein DF; Suntharalingam J; Swietlik EM; Toshner MR; van Heel DA; Vonk Noordegraaf A; Waisfisz Q; Wharton J; Wort SJ; Ouwehand WH; Soranzo N; Lawrie A; Upton PD; Wilkins MR; Trembath RC; Morrell NW
    Nat Commun; 2018 Apr; 9(1):1416. PubMed ID: 29650961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
    Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
    ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension.
    Maloney JP; Stearman RS; Bull TM; Calabrese DW; Tripp-Addison ML; Wick MJ; Broeckel U; Robbins IM; Wheeler LA; Cogan JD; Loyd JE
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L541-54. PubMed ID: 22198906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.